Cargando…

Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine

The leishmaniases are a complex of vector-borne diseases caused by protozoan parasites of the genus Leishmania. LEISHDNAVAX is a multi-antigen, T-cell epitope-enriched DNA vaccine candidate against human leishmaniasis. The vaccine candidate has been proven immunogenic and showed prophylactic efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riede, O, Seifert, K, Oswald, D, Endmann, A, Hock, C, Winkler, A, Salguero, F J, Schroff, M, Croft, S L, Juhls, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530203/ https://www.ncbi.nlm.nih.gov/pubmed/25871827 http://dx.doi.org/10.1038/gt.2015.35

Ejemplares similares

Cationic Lipid-Formulated DNA Vaccine against Hepatitis B Virus: Immunogenicity of MIDGE-Th1 Vectors Encoding Small and Large Surface Antigen in Comparison to a Licensed Protein Vaccine
por: Endmann, Anne, et al.
Publicado: (2014)

Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma
por: Mählmann, Kathrin, et al.
Publicado: (2015)

Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma
por: Mählmann, Kathrin, et al.
Publicado: (2015)

Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects
por: Tiffany, Courtney, et al.
Publicado: (2022)

Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease
por: LeWitt, Peter A., et al.
Publicado: (2018)

Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis
por: Voak, Andrew A., et al.
Publicado: (2017)

Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
por: Li, Yingxin, et al.
Publicado: (2023)

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models
por: Chettab, Kamel, et al.
Publicado: (2023)

Preclinical evaluation of topically-administered PEGylated Fab’ lung toxicity
por: Freches, Danielle, et al.
Publicado: (2019)

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
por: Adler-Moore, Jill, et al.
Publicado: (2019)

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
por: Wyllie, Susan, et al.
Publicado: (2019)

Management of trypanosomiasis and leishmaniasis
por: Barrett, Michael P., et al.
Publicado: (2012)

Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison
por: Richard, Brigitte M., et al.
Publicado: (2011)

Epidermal Carcinogenesis in the Mouse by Intraperitoneally Administered Urethane Followed by Repeated Applications of Croton Oil
por: Ritchie, A. C.
Publicado: (1957)

Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial
por: Buchtele, Nina, et al.
Publicado: (2020)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis
por: Voak, Andrew A., et al.
Publicado: (2021)

DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
por: Mowbray, Charles E., et al.
Publicado: (2021)

Evaluation of a Self-Administered Oral Glucose Tolerance Test
por: Bethel, M. Angelyn, et al.
Publicado: (2013)

Reporting preclinical anesthesia study (REPEAT): Evaluating the quality of reporting in the preclinical anesthesiology literature
por: Fergusson, Dean A., et al.
Publicado: (2019)

Reporting and analysis of repeated measurements in preclinical animals experiments
por: Zhao, Jing, et al.
Publicado: (2019)

Safety and Pharmacokinetics of Intranasally Administered Heparin
por: Harris, Hannah M., et al.
Publicado: (2022)

Safety and Pharmacokinetics of Intranasally Administered Heparin
por: Harris, Hannah M., et al.
Publicado: (2022)

MDC1 PST-repeat region promotes histone H2AX-independent chromatin association and DNA damage tolerance
por: Salguero, Israel, et al.
Publicado: (2019)

Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa
por: Nichols, Timothy C., et al.
Publicado: (2020)

Ocular safety of repeated intravitreal injections of Carboplatin and Digoxin: A preclinical study on the healthy rabbits
por: Khodabande, Alireza, et al.
Publicado: (2021)

Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
por: Loftus, Edward V., et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of (S)-Ketoprofen Co-Administered with Caffeine: A Preclinical Study in Arthritic Rats
por: Medina-López, Raúl, et al.
Publicado: (2018)

Safety and tolerability of repeated sessions of deep transcranial magnetic stimulation in obesity
por: Ferrulli, Anna, et al.
Publicado: (2020)

Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers
por: Naik, Himanshu, et al.
Publicado: (2020)

Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models
por: Gunder, Laura C., et al.
Publicado: (2022)

Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models
por: Teuscher, Kevin B., et al.
Publicado: (2022)

Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis
por: Ashwin, Helen, et al.
Publicado: (2019)

The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study
por: Lee, Mary R., et al.
Publicado: (2018)

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
por: Thomas, Michael G., et al.
Publicado: (2018)

Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers
por: Zhang, Wenhui, et al.
Publicado: (2021)

Clinical and preclinical tolerance protocols for vascularized composite allograft transplantation
por: Yang, Jerry Huanda, et al.
Publicado: (2021)

Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study
por: M. Mansour, Suzan, et al.
Publicado: (2021)

Effects of intragastrically-administered Tepary bean lectins on digestive and immune organs: Preclinical evaluation
por: Alatorre-Cruz, Julia María, et al.
Publicado: (2017)

Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET
por: Matsumoto, Hiroki, et al.
Publicado: (2022)

Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis
por: Jesus, Jéssica Adriana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nivvssphqjqe750d6k97hg85lr